| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.21 | 6e-07 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.17 | 4e-06 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0005 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0006 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0007 |